Methylphenidate Film, Extended Release Shortage
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
The FDA lists Methylphenidate Film, Extended Release as a current shortage, though Noven Pharmaceuticals reports availability across multiple strengths.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on August 6, 2026 and geographically references United States. Its severity classification of "low" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Methylphenidate.
What's in Shortage
Methylphenidate Film, Extended Release (brand name: METHYLPHENIDATE TRANSDERMAL SYSTEM) is in current shortage status. The dosage form is Film, Extended Release in the therapeutic category of Psychiatry. The shortage was first posted on 02/28/2025 and last updated on 07/21/2026.
Which Manufacturers Are Affected
- Noven Pharmaceuticals, Inc.: Available (Distributed by Padagis US LLC). Presentations include 20 mg (NDC 0574-2420-65), 15 mg (NDC 0574-2415-65), 10 mg (NDC 0574-2410-65), and 30 mg (NDC 0574-2430-65). Contact: 800-455-8070.
Why There's a Shortage
No specific reason was provided in the source data.
What Patients Should Do
Patients should talk to their pharmacist, ask about alternatives if needed, and contact the manufacturer for availability information. Always consult your healthcare provider before making any changes to your medication. This article does not provide medical advice.
Source
FDA Drug Shortage Database
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Frequently Asked Questions
Common questions about this FDA drug-shortage notice.